University of Leicester, United Kingdom Prof. David Harris, FRACP Centre for Transplantation and Renal Research, University of Sydney at Westmead Hospital, Sydney, Australia Dr. Kailash Jindal, FRCPC Department of Medicine, University of Alberta, Edmonton, Canada Dr. Mohamed A. Osman, MD Department of Medicine, University of Alberta, Edmonton, Canada Syed Saad, BSci Department of Medicine, University of Alberta, Edmonton, Canada Dr. Vivekanand Jha, PhD George Institute for Global Health, New Delhi, Postgraduate Institute for Medical Education and Research, Chandigarh, India Dr. Boris Bikvov, PhD Moscow State University of Medicine and Dentistry, Moscow, Russia Natasha Wiebe, MMath Alberta Kidney Disease Network, University of Alberta, Edmonton, Canada Dr. Angela Yee-Moon Wang, PhD Department of Medicine, University of Hong Kong, Hong Kong Dr. Csaba Kovesdy, PhD University of Tennessee Health Science Center, Memphis, United States GKHA Steering Committee GKHA Working Group 8 | Acknowledgements ISN Global Kidney Health Atlas | 2019 Professor David Johnson PSM, MB, BS (Hons, Univ Medal), FRACP, DMed (Res), FASN, PhD (Syd) Director, Metro South and Ipswich Nephrology and Transplant Services (MINTS) Medical Director, Queensland Renal Transplant Services ARTS Building Princess Alexandra Hospital 199 Ipswich Road Woolloongabba Qld 4102 Australia Dr. David Johnson is full-time Director of the Metro South and Ipswich Nephrology and Transplant Service (MINTS) and Medical Director of the Queensland Renal Transplant Service at Princess Alexandra Hospital, Brisbane, Australia; Professor of Medicine and Professor of Population Health at University of Queensland; and Director of the Centre for Kidney Disease Research, Brisbane, Australia. He has a number of international leadership responsibilities, including President of the International Society for Peritoneal Dialysis, Councillor of the International Society of Nephrology (ISN), Co-Chair of the ISN Global Kidney Health Atlas, Co-Chair of the Global PDOPPS Steering Committee and Chair of SONGPD. He is currently a chair or member of 10 national and 6 international guideline groups and has influenced policy and practice through his leadership as Deputy Chair of the Australian NHMRC Better Evidence and Translation in Chronic Kidney Disease (BEAT-CKD) program, Deputy Chair of the Australasian Kidney Trials Network (AKTN), Chair of the Primary Healthcare Education Advisory Committee to Kidney Health Australia (PEAK), Co-Chair of the Australasian Creatinine and eGFR Consensus Working Party, Co-Chair of the Australasian Proteinuria Consensus Working Party, Member and PastChair of the ANZDATA Registry Peritoneal Dialysis Working Group, and Past-Chair of the Queensland Statewide Renal Clinical Network. Having published over 800 original manuscripts in peer-reviewed journals and presented over 470 abstracts at national and international scientific meetings, he brings critical expertise in designing and conducting multi-center, multi-national randomized controlled trials (RCTs), developing national and international registries, and using innovative research methodologies (such as registrybased RCTs). He has held lead roles in over 40 recent clinical studies, including high-impact, large, multi-center RCTs that have informed global clinical practice (e.g., IDEAL, balANZ, HONEYPOT, TESTING, HERO, IMPENDIA), and is currently principal investigator of the CKD-FIX trial. He has won numerous awards for both his basic science and clinical research studies, including the Australian and New Zealand Society of Nephrology TJ Neale Award for “outstanding contributions to nephrologic science” (2005), the U.S. National Kidney Foundation International Distinguished Medal (2014) and the Canadian Society of Nephrology Dimitrios Oreopoulos Award (2017). He was a Queensland finalist for the Australian of the Year Award in 2009 and was awarded a Public Service Medal by the Governor-General of Australia in 2011 for outstanding public service, particularly for research into the early detection and management of kidney disease. GKHA Co-Chairs ISN Global Kidney Health Atlas | 2019 Acknowledgements | 9 Dr. Aminu K Bello MD, PhD, FRCP, FACP, FASN Associate Professor/Consultant Nephrologist, Division of Nephrology & Immunology, Faculty of Medicine, University of Alberta 11-107 Clinical Sciences Building Faculty of Medicine & Dentistry University of Alberta Edmonton, AB T6G 2G3 Canada Dr. Aminu Bello qualified as MD in Nigeria and underwent specialist clinical training in internal medicine and nephrology in Nigeria, the United Kingdom, and Canada. He obtained the Membership of the Royal College of Physicians (MRCP), and completed his Masters and PhD degrees in Nephrology/Epidemiology at the University of Sheffield in the United Kingdom (under the supervision of Prof Meguid El-Nahas). After completing his PhD, he went on to complete a post-doctoral clinical and research fellowship in nephrology at the University of Alberta, Canada (under the supervision of Dr. Marcello Tonelli). Dr. Bello is a physician-scientist with major research interests in improving outcomes of patients with CKD. He is a member of the Alberta Kidney Disease Network (AKDN): a team of scientists, policymakers, clinical leaders, educators,